About The Hematology Program is part of the Division of Hematology and Oncology. Hematology is the study of disorders of the blood and blood-forming tissues. Hematologists are physicians who treat a wide array of malignant (or cancerous) disorders - such as leukemia, multiple myeloma, Hodgkin's Disease and non-Hodgkin's lymphoma - and benign (or non-cancerous) illnesses - such as anemia, coagulation disorders and various blood cell anomalies.
- Bruce Cheson, MD: Deputy Chief of Division of Hematology/Oncology, Director of Hematology Services
- Philip Cohen, MD
- Craig Kessler, MD: Director, Clinical Coagulation Laboratory
Our care team uses state-of-the-art treatments and comprehensive supportive services to provide the best care possible for those suffering from hematologic disorders. Our attending physicians work closely with advanced nurse practitioners, and clinical and research nurses. You will have access to Lombardi's social workers, nutritional counselors, pastoral care team, and palliative care team to provide for all aspects of your physical, mental, emotional and spiritual health.
The clinical research mission of the Georgetown Lombardi Hematology Program is to develop new and better therapies for patients. We offer our patients a wide array of opportunities to participate in clinical research studies relating to hematologic disorders. To view current clinical trials, search the Georgetown Lombardi Clinical Trials Database or select your diagnosis from the list of diseases below:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Hodgkin Lymphoma
- Mutiple Myeloma
- Myelodysplastic/Myeloproliferative Diseases
- Non-Hodgkin Lymphoma